logo

Prelude Therapeutics Inc (PRLD) Stock: Navigating Market Highs and Lows in 52 Weeks

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Prelude Therapeutics Inc’s current trading price is -82.06% away from its 52-week high, while its distance from the 52-week low is 53.15%. The stock’s price range during this period has varied between $0.80 and $6.80. The company, active in the Healthcare sector, saw a trading volume of around 0.9 million for the day, considerably higher average daily volume of 0.48 million observed over the last three months.

Prelude Therapeutics Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $6.80 on 08/14/24, and the lowest price during the same period was recorded at $0.80 on 12/16/24.

How Financial Performance Impacts Market Capitalization

Prelude Therapeutics Inc (PRLD) has experienced a quarterly decline of -36.46% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 67.15M and boasts a workforce of 128 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.8839, with a change in price of -4.2600. Similarly, Prelude Therapeutics Inc recorded 445,418 in trading volume during the last 100 days, posting a change of -77.74%.

How PRLD’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for PRLD stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.10.

PRLD Stock Stochastic Average

As of today, the raw stochastic average of Prelude Therapeutics Inc over the past 50 days is 53.37%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 50.00%. Additionally, the Stochastic %K and %D values for the company were 34.68% and 28.94%, respectively, over the past 20 days.

PRLD Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -4.31%.However, over the last six months, we can see a stronger performance of -76.36%. Over the last 30 days, the price of PRLD has fallen by 37.54%. And in the last five days, it has surged by 18.45%.

Most Popular